ABILIFY

Welcome to the Brand page for “ABILIFY”, which is offered here for In the statement, column 1 lines 6 and 7, and prevention cardiovascular diseases is deleted. column 1 line 8 stroke is deleted. column 1 lines 9 and 10, cancer inflammation and inflammatory diseases, respiratory and infec- is deleted. column 2 lines 1 and 2, tious diseases, auto-immune diseases, antibiotics is deleted.;pharmaceutical preparations for the treatment [ and prevention ] of [ cardiovascular diseases, ] central nervous system diseases and disorders [, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, antibiotics ];.

Its status is currently believed to be active. Its class is unavailable. “ABILIFY” is believed to be currently owned by “Otsuka Pharmaceutical Co., Ltd.”